Coloplast A/S (CLPBF) is a publicly traded company in the Healthcare sector, operating within the Medical - Instruments & Supplies industry. The company is headquartered in Humlebæk, Denmark. The current CEO is Lars Soren Rasmussen.
CLPBF has IPO date of 2000-08-09, 16,741 full-time employees, listed on the Other OTC, a market capitalization of $13.54B.
Coloplast A/S is a Danish healthcare company founded in 1954 that develops and markets intimate healthcare products and services globally, with significant operations in North America and Europe. The company operates through four primary segments: Chronic Care, Interventional Urology, Voice and Respiratory Care, and Wound & Skin Care. Its product portfolio includes ostomy care solutions like SenSura and Brava brands, continence management products such as catheters and irrigation systems, wound and skin care dressings, and surgical devices for urological and gynecological conditions. The company also manufactures voice and respiratory care products for patients with neck and tracheal stomas under the Provox and TRACOE brands. Through its diversified product range and established market presence, Coloplast serves patients requiring specialized care for chronic conditions and post-surgical management.
